Financials
- Market Capitalization 228.58 M
- Employee 77
- Founded 2017
- CEO N/A
- Website www.scribetx.com
- Headquarter Delaware, United States
- FIGI BBG00RR3PF94
- Industry N/A
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3604 | BRRK Bluerock Acquisition Corp. II Units | 9.85 USD | +0.51% | -0.30% | -0.30% | -0.30% | 229.61 M USD | ||
| 3606 | TVIV Texas Ventures Acquisition IV Corp Class A Ordinary Shares | 9.98 USD | 0.00% | 0.00% | +0.10% | +0.60% | 229.54 M USD | ||
| 3616 | MRCO Mercator Acquisition Corp. Class A Ordinary Shares | 9.8800 USD | 0.00% | 0.00% | 0.00% | +0.41% | 227.24 M USD | ||
| 3620 | SUJA Suja Life, Inc. Class A Common Stock | 5.84 USD | -8.03% | -17.05% | -39.86% | -67.56% | 225.57 M USD |
Frequently asked questions about Scribe Therapeutics Inc. Common Stock
What is the Scribe Therapeutics Inc. Common Stock stock price today?
The current price of Scribe Therapeutics Inc. Common Stock (SCTX) is 12.07. Over the past 24 hours, the stock has changed by -8.70%. Follow the SCTX chart for real-time price dynamics.
What is the stock ticker of Scribe Therapeutics Inc. Common Stock?
Scribe Therapeutics Inc. Common Stock trades under the ticker SCTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Scribe Therapeutics Inc. Common Stock stock going up?
SCTX has changed by -26.98% over the last week, -36.47% over the last month, and -51.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Scribe Therapeutics Inc. Common Stock?
Scribe Therapeutics Inc. Common Stock currently has a market capitalization of 228.58 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Scribe Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Scribe Therapeutics Inc. Common Stock reported earnings of -0.68 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Scribe Therapeutics Inc. Common Stock revenue for the last quarter?
Scribe Therapeutics Inc. Common Stock reported quarterly revenue of 1.64 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Scribe Therapeutics Inc. Common Stock net income for the last quarter?
Scribe Therapeutics Inc. Common Stock reported net income of -9.86 M for the last quarter. The previous quarter showed -6.48 M, which means net income changed by -52.28%.
How many employees does Scribe Therapeutics Inc. Common Stock have?
As of the latest available data, Scribe Therapeutics Inc. Common Stock has 77 employees. Workforce size can provide additional context about the company's scale and operations.
What is Scribe Therapeutics Inc. Common Stock EBITDA?
Scribe Therapeutics Inc. Common Stock EBITDA is -10.26 M, and its EBITDA margin is -627.26%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Scribe Therapeutics Inc. Common Stock stock?
You can buy Scribe Therapeutics Inc. Common Stock (SCTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Scribe Therapeutics Inc. Common Stock stock?
Investing in Scribe Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SCTX chart and related analysis on metatrader.com as part of your research.